Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapyNina Dickgreber, Patrizia Stoitzner, Yan Bai, et al.Immunology and Cell Biology|June 16, 2016
Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21Natalie Lorenz, Evert Jan Loef, Inken D Kelch, et al.Tissue Engineering. Part A|January 22, 2015
In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regenerationDavid S Musson, Dorit Naot, Ashika Chhana, et al.Journal for Immunotherapy of Cancer|April 11, 2024
Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumorsJared M Odegard, Ahmed A Othman, Kai-Wen Lin, et al.Frontiers in Immunology|February 17, 2025
A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancerLuis Munoz-Erazo, Saem Mul Park, Shelly Lin, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Competition between CTL narrows the immune response induced by prime-boost vaccination protocolsMichael J Palmowski, Ed Man-Lik Choi, Ian F Hermans, et al.Immunology and Cell Biology|August 3, 2020
Migratory cues controlling B-lymphocyte trafficking in human lymph nodesSaem Mul Park, Anna Es Brooks, Chun-Jen J Chen, et al.European Journal of Immunology|April 13, 2007
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionLinda Wooldridge, Anna Lissina, Jonathan Vernazza, et al.Journal of Hepatology|December 22, 2023
Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppressionEdward J Gane, P Rod Dunbar, Anna E Brooks, et al.Molecular Therapy. Nucleic Acids|March 3, 2025
Enhanced HDR-mediated correction of heterozygous <i>COL7A1</i> mutations for recessive dystrophic epidermolysis bullosaJohn M T Hunt, Alex du Rand, Daniel Verdon, et al.Pageof 11